Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-25 @ 1:33 AM
NCT ID:
NCT06483594
Eligibility Criteria:
Inclusion Criteria:
1. Case group inclusion criteria:
1. Time period of inclusion: 2009-2023 (15 years)
2. Patients with HCC diagnosed by clinical or pathological criteria according to the National Health Commission guidelines for the diagnosis and treatment of primary liver cancer who underwent TACE after surgery and developed postoperative liver abscess.
3. Appendix: Diagnostic criteria for liver abscess after TACE:
Condition 1: CT images show typically low-density lesions with or without air and fluid levels
Condition 2:
* positive blood culture
* Percutaneous drainage or aspiration is purulent or culture-positive
* Symptoms of infection such as fever/chills, accompanied by elevated inflammatory markers such as white blood cell count, C-reactive protein, or procalcitonin.
2. Control group inclusion criteria
1. Patients with HCC without liver abscess who underwent TACE in the same center within the week of treatment in the case group.
\-
Exclusion Criteria:
<!-- -->
1. Clinical and follow-up data were incomplete
2. Loss to follow-up
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06483594
Study Brief:
Protocol Section:
NCT06483594